{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T17:19:11Z","timestamp":1787678351152,"version":"build-2784847793"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:00:00Z","timestamp":1782172800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bioorganic Chemistry"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bioorg.2026.110155","type":"journal-article","created":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T23:34:50Z","timestamp":1782171290000},"page":"110155","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Tetrazolo[1,5-c]quinazolines as anti-Klebsiella pneumoniae scaffolds: Bridging in vitro activity and multi-target docking prediction"],"prefix":"10.1016","volume":"180","author":[{"given":"Lyudmyla","family":"Antypenko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oleksii","family":"Antypenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lyudmyla","family":"Lyashko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Fominichenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentyna","family":"Kozyrieva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serhii","family":"Kovalenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mieko","family":"Arisawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.bioorg.2026.110155_bb0005","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3797\/scipharm.1208-13","article-title":"Design and evaluation of novel antimicrobial and anticancer agents among tetrazolo[1,5-c]quinazoline-5-thione S-derivatives","volume":"81","author":"Antypenko","year":"2013","journal-title":"Sci. Pharm."},{"key":"10.1016\/j.bioorg.2026.110155_bb0010","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.arabjc.2014.09.009","article-title":"Potential of N-aryl(benzyl,heteryl)-2-(tetrazolo[1,5-c]quinazolin-5-ylthio)acetamides as anticancer and antimicrobial agents","volume":"9","author":"Antypenko","year":"2016","journal-title":"Arab. J. Chem."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110155_bb0015","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202300029","article-title":"5,6-Dihydrotetrazolo[1,5-c]quinazolines: toxicity prediction, synthesis, antimicrobial activity, molecular docking, and perspectives","volume":"356","author":"Antypenko","year":"2023","journal-title":"Arch. Pharm."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110155_bb0020","doi-asserted-by":"crossref","first-page":"816","DOI":"10.3390\/jof10120816","article-title":"Evaluation of fifteen 5,6-dihydrotetrazolo[1,5-c]quinazolines against Nakaseomyces glabrata: integrating in vitro studies, molecular docking, QSAR, and in silico toxicity assessments","volume":"10","author":"Antypenko","year":"2024","journal-title":"Journal of Fungi"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110155_bb0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2174\/138920108783497668","article-title":"Mechanism and inhibition of LpxC: an essential zinc-dependent deacetylase of bacterial lipid a synthesis","volume":"9","author":"Barb","year":"2008","journal-title":"Curr. Pharm. Biotechnol."},{"issue":"12","key":"10.1016\/j.bioorg.2026.110155_bb0030","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1021\/bi6025165","article-title":"Inhibition of lipid a biosynthesis as the primary mechanism of CHIR-090 antibiotic activity in Escherichia coli","volume":"46","author":"Barb","year":"2007","journal-title":"Biochemistry"},{"issue":"1","key":"10.1016\/j.bioorg.2026.110155_bb0035","doi-asserted-by":"crossref","first-page":"5092","DOI":"10.1038\/s41467-024-49349-z","article-title":"International and regional spread of carbapenem-resistant Klebsiella pneumoniae in Europe","volume":"15","author":"Budia-Silva","year":"2024","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.bioorg.2026.110155_bb0040","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1128\/AAC.46.6.1793-1799.2002","article-title":"Antibacterial activities and characterization of novel inhibitors of LpxC","volume":"46","author":"Clements","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110155_bb0045","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fimmu.2013.00078","article-title":"Peptidoglycan glycosyltransferase substrate mimics as templates for the design of new antibacterial drugs","volume":"4","author":"Derouaux","year":"2013","journal-title":"Front. Immunol."},{"issue":"29","key":"10.1016\/j.bioorg.2026.110155_bb0050","doi-asserted-by":"crossref","first-page":"11663","DOI":"10.1073\/pnas.1205073109","article-title":"Avibactam is a covalent, reversible, non-\u03b2-lactam \u03b2-lactamase inhibitor","volume":"109","author":"Ehmann","year":"2012","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"5","key":"10.1016\/j.bioorg.2026.110155_bb0055","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1074\/jbc.M411325200","article-title":"Evidence that the fosfomycin target Cys115 in UDP-N-acetylglucosamine enolpyruvyl transferase (MurA) is essential for product release","volume":"280","author":"Eschenburg","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bioorg.2026.110155_bb0060","author":"European Committee on Antimicrobial Susceptibility Testing"},{"key":"10.1016\/j.bioorg.2026.110155_bb0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2019.111744","article-title":"Current scenario of tetrazole hybrids for antibacterial activity","volume":"184","author":"Gao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"issue":"32","key":"10.1016\/j.bioorg.2026.110155_bb0070","doi-asserted-by":"crossref","first-page":"9663","DOI":"10.1021\/bi970294+","article-title":"The entropic penalty of ordered water accounts for weaker binding of the antibiotic novobiocin to a resistant mutant of DNA gyrase: a thermodynamic and crystallographic study","volume":"36","author":"Holdgate","year":"1997","journal-title":"Biochemistry"},{"issue":"3","key":"10.1016\/j.bioorg.2026.110155_bb0075","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/s41564-024-01612-1","article-title":"Carbapenem-resistant Klebsiella pneumoniae capsular types, antibiotic resistance and virulence factors in China: a longitudinal, multi-Centre study","volume":"9","author":"Hu","year":"2024","journal-title":"Nat. Microbiol."},{"key":"10.1016\/j.bioorg.2026.110155_bb0080","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s43088-024-00470-4","article-title":"Overcoming Klebsiella pneumoniae antibiotic resistance: new insights into mechanisms and drug discovery","volume":"13","author":"Huy","year":"2024","journal-title":"Beni-Suef University Journal of Basic and Applied Sciences"},{"issue":"6","key":"10.1016\/j.bioorg.2026.110155_bb0085","first-page":"436","article-title":"Cytotoxic and genotoxic effects of some substituted tetrazolo[1,5-c]quinazolines","volume":"51","author":"Jantova","year":"2004","journal-title":"Neoplasma"},{"issue":"11","key":"10.1016\/j.bioorg.2026.110155_bb0090","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/13543776.2017.1360282","article-title":"LpxC inhibitors: a patent review (2010\u20132016)","volume":"27","author":"Kalinin","year":"2017","journal-title":"Expert Opin. Ther. Pat."},{"issue":"2","key":"10.1016\/j.bioorg.2026.110155_bb0095","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3390\/antibiotics12020234","article-title":"Carbapenem-resistant Klebsiella pneumoniae: virulence factors, molecular epidemiology and latest updates in treatment options","volume":"12","author":"Karampatakis","year":"2023","journal-title":"Antibiotics"},{"issue":"12","key":"10.1016\/j.bioorg.2026.110155_bb0100","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.2174\/1568026622666220307144015","article-title":"The antibacterial activity of quinazoline and quinazolinone hybrids","volume":"22","author":"Li","year":"2022","journal-title":"Curr. Top. Med. Chem."},{"issue":"W1","key":"10.1016\/j.bioorg.2026.110155_bb0105","doi-asserted-by":"crossref","first-page":"W159","DOI":"10.1093\/nar\/gkac394","article-title":"CB-Dock2: improved protein-ligand blind docking by integrating cavity detection, docking and homologous template fitting","volume":"50","author":"Liu","year":"2022","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.bioorg.2026.110155_bb0110","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/nrd2201","article-title":"Drugs for bad bugs: confronting the challenges of antibacterial discovery","volume":"6","author":"Payne","year":"2007","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10","key":"10.1016\/j.bioorg.2026.110155_bb0115","doi-asserted-by":"crossref","first-page":"5873","DOI":"10.1128\/AAC.01019-15","article-title":"Carbapenemase-producing Klebsiella pneumoniae, a key pathogen set for global nosocomial dominance","volume":"59","author":"Pitout","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.bioorg.2026.110155_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.micpath.2020.104245","article-title":"A computational subtractive genome analysis for the characterization of novel drug targets in Klebsiella pneumoniae strain PittNDM01","volume":"146","author":"Rafiq","year":"2020","journal-title":"Microb. Pathog."},{"key":"10.1016\/j.bioorg.2026.110155_bb0125","doi-asserted-by":"crossref","unstructured":"Rosas, N. C., Wilksch, J., Barber, J., Li, J., Wang, Y., Sun, Z., Rocker, A., Webb, C. T., Perlaza-Jim\u00e9nez, L., Stubenrauch, C. J., Dhanasekaran, V., Song, J., Taiaroa, G., Davies, M., Strugnell, R. A., Bao, Q., Zhou, T., McDonald, M. J., & Lithgow, T. (2023). The evolutionary mechanism of non-carbapenemase carbapenem-resistant phenotypes in Klebsiella spp. eLife, 12, e83107. doi:https:\/\/doi.org\/10.7554\/eLife.83107.","DOI":"10.7554\/eLife.83107"},{"issue":"15","key":"10.1016\/j.bioorg.2026.110155_bb0130","doi-asserted-by":"crossref","first-page":"4406","DOI":"10.1021\/bi0300229","article-title":"Structure-activity studies of the inhibition of FabI, the enoyl reductase from Escherichia coli, by triclosan: kinetic analysis of mutant FabIs","volume":"42","author":"Sivaraman","year":"2003","journal-title":"Biochemistry"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110155_bb0135","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1039\/C9MD00557A","article-title":"Cyclic boronates as versatile scaffolds for KPC-2 \u03b2-lactamase inhibition","volume":"11","author":"Tooke","year":"2020","journal-title":"RSC Medicinal Chemistry"},{"issue":"4","key":"10.1016\/j.bioorg.2026.110155_bb0140","doi-asserted-by":"crossref","first-page":"5528","DOI":"10.3390\/molecules20045528","article-title":"Tetrazolium compounds: synthesis and applications in medicine","volume":"20","author":"Wei","year":"2015","journal-title":"Molecules"},{"key":"10.1016\/j.bioorg.2026.110155_bb0145","author":"World Health Organization"},{"key":"10.1016\/j.bioorg.2026.110155_bb0150","author":"World Health Organization"}],"container-title":["Bioorganic Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0045206826006917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:29:53Z","timestamp":1787675393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0045206826006917"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":30,"alternative-id":["S0045206826006917"],"URL":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110155","relation":{},"ISSN":["0045-2068"],"issn-type":[{"value":"0045-2068","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tetrazolo[1,5-c]quinazolines as anti-Klebsiella pneumoniae scaffolds: Bridging in vitro activity and multi-target docking prediction","name":"articletitle","label":"Article Title"},{"value":"Bioorganic Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bioorg.2026.110155","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110155"}}